Loading clinical trials...

A Research Study of How a New Medicine NNC0365-3769 (Mim8) Works in the Body of Healthy People | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT05127473

A Research Study of How a New Medicine NNC0365-3769 (Mim8) Works in the Body of Healthy People

NN0365-3769 (Mim8) is a study medicine with the potential to prevent and reduce bleeding in people with haemophilia A (an inherited disorder in which blood does not coagulate properly). This study wi...

Lead sponsor: Novo Nordisk A/S•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment66

Start dateJul 2021

Last updatedNov 1, 2023

Condition

Healthy Volunteers - Haemophilia A

Locations shown

Novo Nordisk Investigational Site

Mainz

Novo Nordisk Investigational Site

Neuss

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 1, 2023Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions